Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,323Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Zenara Pharma

02 19Angelini Pharma

03 10ENDO OPERATIONS LTD.

04 3ORIFARM GROUP AS

05 6SK Life Science

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000055

Regulatory Info : Approved

Registration Country : Sweden

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000062

Regulatory Info : Approved

Registration Country : Sweden

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 200mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000079

Regulatory Info : Approved

Registration Country : Sweden

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg;12.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000024

Regulatory Info : Approved

Registration Country : Sweden

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 50mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000048

Regulatory Info : Approved

Registration Country : Sweden

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Monastery

Brand Name : Ontozry

Dosage Form : Tablet

Dosage Strength : 12.5mg

Packaging :

Approval Date : 19/05/2022

Application Number : 68051

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 200 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 150 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 50 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 12.5MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank